These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 11593357)
1. Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival. Saga Y; Mizukami H; Suzuki M; Urabe M; Kume A; Nakamura T; Sato I; Ozawa K Gene Ther; 2001 Oct; 8(19):1450-5. PubMed ID: 11593357 [TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Saimura M; Nagai E; Mizumoto K; Maehara N; Okino H; Katano M; Matsumoto K; Nakamura T; Narumi K; Nukiwa T; Tanaka M Cancer Gene Ther; 2002 Oct; 9(10):799-806. PubMed ID: 12224019 [TBL] [Abstract][Full Text] [Related]
3. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4. Saimura M; Nagai E; Mizumoto K; Maehara N; Minamishima YA; Katano M; Matsumoto K; Nakamura T; Tanaka M Clin Cancer Res; 2002 Oct; 8(10):3243-9. PubMed ID: 12374695 [TBL] [Abstract][Full Text] [Related]
4. Gallbladder cancer treatment using adenovirus expressing the HGF/NK4 gene in a peritoneal implantation model. Tanaka T; Shimura H; Sasaki T; Narumi K; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Ikeda S Cancer Gene Ther; 2004 Jun; 11(6):431-40. PubMed ID: 15118756 [TBL] [Abstract][Full Text] [Related]
5. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990]. Lai RX; Yuan SZ; Nakamura T Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922 [TBL] [Abstract][Full Text] [Related]
6. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993 [TBL] [Abstract][Full Text] [Related]
8. [Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice]. Kubota T; Fujiwara H; Amaike H; Takashima K; Inada S; Atsuji K; Yoshimura M; Matsumoto K; Nakamura T; Yamagishi H Gan To Kagaku Ryoho; 2002 Nov; 29(12):2258-60. PubMed ID: 12484049 [TBL] [Abstract][Full Text] [Related]
9. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice. Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388 [TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989 [TBL] [Abstract][Full Text] [Related]
12. [Suppression of peritoneal implantation by NK4 and its mechanisms]. Atsuji K; Fujiwara H; Kubota T; Inada S; Takashima K; Yoshimura M; Ueda Y; Yamagishi H Gan To Kagaku Ryoho; 2004 Oct; 31(11):1777-9. PubMed ID: 15553712 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppression effect using NK4, a molecule acting as an antagonist of HGF, on human gastric carcinomas. Hirao S; Yamada Y; Koyama F; Fujimoto H; Takahama Y; Ueno M; Kamada K; Mizuno T; Maemondo M; Nukiwa T; Matsumoto K; Nakamura T; Nakajima Y Cancer Gene Ther; 2002 Aug; 9(8):700-7. PubMed ID: 12136432 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells. Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241 [TBL] [Abstract][Full Text] [Related]
15. Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression. Fujiwara H; Kubota T; Amaike H; Inada S; Takashima K; Atsuji K; Yoshimura M; Maemondo M; Narumi K; Nukiwa T; Matsumoto K; Nakamura T; Hagiwara A; Yamagishi H Cancer Gene Ther; 2005 Feb; 12(2):206-16. PubMed ID: 15486556 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Kohno T; Mizukami H; Suzuki M; Saga Y; Takei Y; Shimpo M; Matsushita T; Okada T; Hanazono Y; Kume A; Sato I; Ozawa K Cancer Res; 2003 Aug; 63(16):5091-4. PubMed ID: 12941839 [TBL] [Abstract][Full Text] [Related]
17. Possible inhibition of cancer cell adhesion to the extracellular matrix in NK4-induced suppression of peritoneal implantation. Yoshimura M; Fujiwara H; Kubota T; Amaike H; Takashima K; Inada S; Atsuji K; Araki Y; Matsumoto K; Nakamura T; Yamagishi H Anticancer Res; 2005; 25(6B):3847-54. PubMed ID: 16309170 [TBL] [Abstract][Full Text] [Related]
18. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice]. Lai RX; Zhang SN; Nakamura T; Yuan SZ Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131 [TBL] [Abstract][Full Text] [Related]
19. Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft. Huang X; Lin T; Gu J; Zhang L; Roth JA; Stephens LC; Yu Y; Liu J; Fang B Gene Ther; 2002 Oct; 9(20):1379-86. PubMed ID: 12365003 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. Brockmann MA; Papadimitriou A; Brandt M; Fillbrandt R; Westphal M; Lamszus K Clin Cancer Res; 2003 Oct; 9(12):4578-85. PubMed ID: 14555533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]